Innovating Works

FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA

Activa
Mostrando 1 al 20 de 23 resultados
GRADIENT: Impact of gut microbiota targeted dietary intervention on obesity: A precision medicine approach FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 The main objective is to analyze the impact of dietary hypocaloric interventions based on their capacity to generate ketone bodies in differ...
2024-05-15 - 2027-01-05 | Financiado
MORBIUS: Cure for Miniature Brittle Bones: Treatment of Osteogenesis ImpeRfecta patient-derived Bone organoid... FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Osteogenesis Imperfecta (OI), also known as brittle bone disease, is a prevalent rare skeletal condition. With limited treatment options ava...
2024-05-12 - 2027-06-30 | Financiado
ORACLE: Optimize risk prediction after myocardial infarction through artificial intelligence and multidimens... FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA tramitó un HORIZON EUROPE: ERC-2023-STG Myocardial infarction (MI) is a leading cause of death worldwide. After MI, long-term antithrombotic therapy is crucial to prevent recurrent...
2023-12-15 - 2029-03-31 | Financiado
ORTHO-ALLO-UNION: ORTHOpaedic treatment with ALLOgenic combined ATMP in long bone fracture delayed UNION and non union... SERVICIO MADRILENO DE SALUD tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-TOOL-05 Bone fracture with delay or failure to heal is a condition with huge health impact. Although only a small proportion of long bone fractures...
2023-11-28 - 2028-11-30 | Financiado
LIVERATION: Unravelling the impact of Radiofrequency in liver surgery the key to decrease local recurrence? CONSORCIO MAR PARC DE SALUT DE BARCELONA tramitó un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 Colorectal cancer (CRC) ranks fourth in cancer deaths worldwide. Between 20% and 30% of patients with advanced CRC have liver metastases (CR...
2023-05-08 - 2028-05-31 | Financiado
PRE-BIT: Understanding the role of B cell phenotypes as a predictor of the efficacy and prognosis of allergen... FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-PF-01 Allergic rhinitis (AR) is one the more prevalent respiratory allergic disease affecting 20-30% of the global population. The inflammatory pr...
2023-03-01 - 2025-03-31 | Financiado
ERA4Health: Fostering a European Research Area for Health Research INSTITUTO DE SALUD CARLOS III (ISCIII) tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-03 Excellent EU programs push health R&I but are not sufficient. Synergy with strategic initiatives in MS and a new model for impactful collabo...
2022-11-25 - 2029-10-31 | Financiado
halt-RONIN: Discovering chronic inflammation biomarkers that define key stages in the Healthy to NASH non alcoh... Universidad Complutense de Madrid tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a si...
2022-11-22 - 2026-11-30 | Financiado
ASSERT: Development of a nanotechnology based innovative assay for the diagnosis of allergy to Betalactams FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA tramitó un H2020: H2020-MSCA-IF-2020 Betalactams (BL) are the most widely used antibiotics and the first-choice drugs to control several bacterial infections, however, they can...
2021-03-24 - 2024-09-09 | Financiado
3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD tramitó un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado
IMMUNOMARK: Omics integration for precision cancer immunotherapy FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA tramitó un H2020: H2020-MSCA-IF-2017 The development of immunotherapies based on checkpoint inhibitors marks the beginning of a new era in the treatment of cancer, with 20-30% o...
2018-02-19 - 2020-02-29 | Financiado
DIRECtA: Targeting the Endocannabinoid System within Islets of Langerhans to Protect against Immune Destructi... FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA tramitó un H2020: H2020-MSCA-IF-2016 Europe has the highest prevalence per capita of children with type 1 diabetes (T1D), an autoimmune disease with no cure that results in prog...
2017-03-06 - 2020-01-02 | Financiado
Dendrimmuneassays: Development of sophisticated dendrimeric nanostructural materials with potential applications in dru... FUNDACIÓN INSTITUTO MEDITERRÁNEO PARA EL AVANCE DE LA BIOTECNOLOGÍA Y LA INVESTIGACIÓN SANITARIA tramitó un FP7: Nowadays drug allergy is considered a major public health problem in developed countries. Its correct diagnosis is very important for the ad...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.